Description:
Newomics Inc., an early stage biotechnology company, commercializes innovative (New) and integrative (Omics) platforms and solutions for personalized healthcare. The company's proprietary technology is based on silicon-microfluidic-chip for liquid chromatography-mass spectrometry (LC-MS), offering unprecedented robustness, sensitivity, specificity, and throughput for analyzing molecules from minute amounts of biospecimens such as blood and urine.